Literature DB >> 10666223

Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.

T Marafioti1, M Hummel, H D Foss, H Laumen, P Korbjuhn, I Anagnostopoulos, H Lammert, G Demel, J Theil, T Wirth, H Stein.   

Abstract

Single cell studies aimed at clarifying the nature and clonality of Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin's disease (HD) have so far produced conflicting results. Using an improved single cell procedure, the HRS cells of 25 patients with nodular sclerosing HD lacking B- and T-cell antigens, with and without Epstein-Barr virus infection, were analyzed for the presence of immunoglobulin (Ig) gene rearrangements. One patient with HD developed follicular lymphoma 2 years later. Both lymphomas originated from a common precursor identified as a germinal center B cell. The data show that all but one of the investigated cases harbored rearranged Ig genes, which were clonal in all instances and carried a high load of somatic mutations. The Ig coding capacity was preserved in 18 of the 24 cases (75%) with rearrangements. However, expression of Ig messenger RNA was not detectable in the HRS cells with the exception of Ig kappa light chain expression in some tumor cells of 1 case. The lack of Ig gene transcription in HRS cells was confirmed by analyzing the HD cell lines L428 and KM-H2 in transient transfection experiments. An Ig promoter/enhancer reporter construct showed virtually no activity in these cells compared to 5 control B-cell lines. We conclude that (1) classical HD is a B-cell lymphoma in most instances, (2) HRS cells are clonal without any exception, (3) they are derived from germinal center B-cells that (4) mostly lack crippling mutations but (5) have consistently lost their Ig gene transcription ability, due to functional defects in the Ig gene regulatory elements. (Blood. 2000;95:1443-1450)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666223

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  86 in total

1.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.

Authors:  Ryouichi Horie; Takuro Watanabe; Kinji Ito; Yasuyuki Morisita; Mariko Watanabe; Takaomi Ishida; Masaaki Higashihara; Marshall Kadin; Toshiki Watanabe
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 3.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

4.  Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma.

Authors:  Ewerton M Maggio; Anke Van Den Berg; Debora de Jong; Arjan Diepstra; Sibrand Poppema
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

5.  Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.

Authors:  A Dutton; J D O'Neil; A E Milner; G M Reynolds; J Starczynski; J Crocker; L S Young; P G Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

6.  Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.

Authors:  Carrie A Thompson; Matthew J Maurer; James R Cerhan; Jerry A Katzmann; Stephen M Ansell; Thomas M Habermann; William R Macon; George J Weiner; Brian K Link; Thomas E Witzig
Journal:  Am J Hematol       Date:  2011-10-17       Impact factor: 10.047

7.  The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.

Authors:  Philip Brown; Teresa Marafioti; Rajko Kusec; Alison H Banham
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

Review 8.  Epidemiology and pathologic features of Hodgkin lymphoma.

Authors:  Shin-ichi Nakatsuka; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 9.  Relationship between Hodgkin's and non-Hodgkin's lymphomas.

Authors:  Rose-Marie Amini; Gunilla Enblad
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

10.  Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus.

Authors:  Christoph Mancao; Markus Altmann; Berit Jungnickel; Wolfgang Hammerschmidt
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.